Kenneth Moch

Kenneth Moch is the current director at Gamida Cell. Prior to this, they were with Cognition Therapeutics, Inc. from October 2016 to March 2021 where they served as an advisor. Kenneth has also been with Gamida Cell Ltd., Zynerba Pharmaceuticals, New York University School of Medicine, and Chimerix, Inc. In 2009, they became the president and CEO of Chimerix, Inc. and a board member in 2013. From 2015 to 2016, they were the managing partner of Salutramed Group, LLC before becoming the president of Euclidian Life Science Advisors, LLC.

Kenneth Moch attended Rye Neck High School. Kenneth then went on to Princeton University where they earned their AB in Biochemistry, with a Minor in Science in Human Affairs (Health Policy). Lastly, they completed their MBA at Stanford University Graduate School of Business.